The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...
Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...
The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, ...